Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV-1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2025-03-13
DOI
https://doi.org/10.1093/cid/ciaf077
Citations
4
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
4.15
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV-1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial

Simiso Mandisa Sokhela, Ernest Asante‐Appiah, Johannes Richard Bogner, Federico Hinestrosa et al.
4 citations
Clinical Infectious Diseases
HIV Research and Treatment
4.15
article

Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV-1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial

Simiso Mandisa Sokhela, Ernest Asante‐Appiah, Johannes Richard Bogner, Federico Hinestrosa, Hiroyuki Gatanaga, Jade Ghosn, Douglas Cunningham, Jean‐Michel Molina, Karen Eves, Todd Correll, Stephanie O. Klopfer, Jürgen Kurt Rockstroh, Pedro Cahn, Michelle C. Fox, Mary L. Pisculli, Roger Paredes, Ying Zhang, Kathleen Squires, Sheetal Kassim, Uchechukwu Nwoke
article en
4 citations

Abstract

No abstract available for this paper.
Clinical Infectious DiseasesVol. 81(2)
Université Claude Bernard Lyon 1 (FR), Délégation Paris 5 (FR), Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Desmond Tutu HIV Foundation (ZA), Inserm (FR), University of the Witwatersrand (ZA), Université Paris Cité (FR), University Hospital Bonn (DE), Hospital Universitario La Paz (ES), LMU Klinikum (DE), IrsiCaixa (ES), Sorbonne Paris Cité (FR), National Center for Global Health and Medicine (JP), Assistance Publique – Hôpitaux de Paris (FR), Fundación Huésped (AR), Hôpital Lariboisière (FR), Orlando Immunology Center (US), Health Foundation (GB), Hôpital Bichat-Claude-Bernard (FR), Hospital Universitari Germans Trias i Pujol (ES), Case Western Reserve University (US), Ludwig-Maximilians-Universität München (DE)
Good health and well-being
Openalex Percentile: Top 7%
HIV Research and Treatment
4.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.